Prasugrel/Clopidogrel Maintenance Dose Washout Study

NCT01014624 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Prasugrel
DRUG: Clopidogrel

Sponsor

Daiichi Sankyo